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An essential element in the pathogenicity of a microorganism is its ability to 
multiply within  the  animal host.  The degree to which  any microbial species 
can multiply, and  the  correlation of that multiplication  with  the production 
of progressive disease might be expected to depend on a number of factors such 
as  toxin  production,  effectiveness of host  defenses,  and  similar host-parasite 
interactions.  Nevertheless,  it  is  reasonable  to  assume  that  in  any particular 
species,  within  certain  limits,  the  number of microorganisms within  a  given 
tissue would provide an index of the degree of involvement of that tissue. 
Specifically with reference to M. tuberculosis it is known that various strains vary in 
their capacity to induce disease in experimental animals. Lurle (2) demonstrated that 
in rabbits, fully virulent bacilli of bovine origin multiplied progressively to the point of 
death of the animal. In contrast, human strains  (not fully virulent for the rabbit) 
multiplied initially but soon the increase in numbers was checked. Lurie also showed 
(3)  that the attenuated BCG strain behaved in rabbits in a  way similar to that of 
tubercle bacilli of human origin. 
Within the past few years techniques have been developed which permit the precise 
enumeration of culturable tubercle bacilli in animal tissues on a fairly large scale and 
with a reasonable degree of safety to personnel.  Using these techniques,  Pierce, Dubos, 
and Schaefer (4) have carefully studied in mice the multiplication of various strains of 
* Presented in part at the 67th Annual Meeting of the Association of American Physicians, 
Atlantic City, New Jersey, May 4 and 5, 1954 (1). 
~: This study was supported in part by grants from the Committee on Medical Research of 
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avirulent, attenuated, and virulent tubercle bacilli.  Among their findings the following 
axe pertinent to the present discussion. 
Certain strains  were truly avirulent and  were unable to multiply in mice. Other 
attenuated  strains underwent multiplication in vivo but could not give rise to progressive 
disease.  With these strains, the maximal numbers of living bacilli recovered from the 
tissues corresponded directly to the severity and duration of the abortive lesions.  In 
the case of the attenuated  and the virulent strains  the census of culturable  bacilli 
present in the lungs was at first lower than that in the spleen, but in the former organ 
it continued to increase throughout the period of observation. In contrast, the micro- 
bial population in the spleen rapidly reached a maximum and then decreased progres- 
sively. These investigators observed that for a given infective dose and a given interval 
of time after inoculation, the maximal census of culturable microorganisms attained in 
the spleen and in the lung proved to be a  direct expression of the virulence of the 
particular strain of tubercle bacilli, 
In reviewing the facts set forth above it seemed reasonable  to believe that 
within a well defined experimental situation the bacterial population of tubercle 
bacilli within tissues of mice might provide a sensitive index of factors influenc- 
ing the course of tuberculous infection.  Specifically with regard to antimicro- 
bial agents used in the treatment of tuberculosis  there appeared to be a  need 
for  methods  of  study  other  than  those  generally  employed.  Conventional 
methods for the assessment  of antituberculous  drug effectiveness rely on pro- 
longation of survival  time of treated  animals  or on the  estimation  of size of 
lesions at autopsy. Both of these methods have many definite advantages but 
also possess deficiencies, especially when they are utilized for evaluation of the 
total  effect of two  or more antimicrobial  drugs  administered  together. 
Accordingly, an investigation has been made of the effects of antituberculous 
drugs, used singly and in multiple drug regimens, on the populations of tubercle 
bacilli in the lung and spleen of mice with a chronic tuberculous infection. The 
results of the initial studies on this subject form the basis of the present report. 
Materials and Methods 
The test microorganisms used for aU experiments were obtained from stock cultures of the 
virulent  strain of Mycobacterium tuberculosis hominis  (H37Rv)  which were maintained  by 
weekly passage in standard tweenl-albumin medium. The cultures were 7 days old at the time 
of use and contained from 2.5 X  l0  T  to 1 X  l0  s viable units of tubercle bacilli per ml. 
Male albino mice (Webster Swiss strain) obtained from Rockland or Carworth Farms were 
used for all experiments. They weighed 15 to 20 gin. when they were received at the laboratory 
and infection customarily was carried out i week after arrival. The mice were housed in metal 
cages (not more than ten animalsper cage) and were fed whole or pulverized standard mouse 
pellets with water ad libit,  um. 
Infection was carried out by intravenous inoculation of 0.2 ml. of a 10  -t dilution of culture 
in 0.1 per cent bovine albumin. 
x Tween 80 is the proprietary  name for the polyoxyethylene derivative of sorbitan mono- 
oleate, obtainable from the Atlas Powder Co., Wilmington. R.  M'.  ~  ~'R., AND  R,  TOMPSETT  739 
Drugs.--Streptomycin was  administered intramuscularly in 4  rag.  amounts  daily.  Iso- 
niazid  2 was administered in the diet by mixing it in a McLellan dry batch mixer with finely 
ground pellets. In all experiments employing isoniazid a concentration of 0.0125 per cent in 
the diet was used. This was originally calculated to administer 25 mg. of isoniazid per kg. of 
body weight daily to a 20 gin. animal that consumes 4 gin. of food per day. Calculations based 
upon weekly simultaneous measurements of food consumption and body weight demonstrated 
the actual dosage of isonlazid so administered to be 18 to 20 mg. per kg. of body weight per 
day throughout the course of the experiments. 
Pyrazinamide  3 and para-amino salicylic acid also were administered in the diet by mixing 
them with pulverized pellets, as described above. Pyrazinamide comprised 2.0 per cent of the 
diet and PAS 0.75 per cent. 
Pyrazinamide is a nicotinamide derivative with the formula: 
"~N/ 
The antituberculous activity of the drug in man was reported by Yeager and his associates (5). 
Preparation  of Tissue  Homogenates.--Mice  were  sacrificed with chloroform, and aseptic 
techniques were  utilized  in removing the organs.  Tissue emulsions were prepared  by the 
method described by Pierce et al. (4) using a teflon homogenizer, grinding in the presence of 
2 per cent bovine albumin. As was the experience of these investigators, the homogenates 
were found to consist of ruptured tissue cells and intact nuclei, among which tubercle bacilli 
could be seen to occur for the most part singly or in small aggregates of 2 to 5 bacilli. 
Organ measurement was achieved by determining the amount of displacement of a measured 
volume (5 ml.)  of diluent (2 per cent bovine albumin). This value was ultimately used  in 
expressing the population of tubercle bacilli in terms of culturable units per mi. of tissue. 
Enumeralion of Tuberd, Bacilli.--The numbers of culturable tubercle bacilli present in the 
infecting inoculum and the homogenates of tissues of infected animals were determined by 
inoculating the surface of solid oleic acid albumin agar (6) with appropriate dilutions of the 
substances, adhering to the principles described by Fenner a  al. (7). 
The oleic acid-albumin agar was incubated for 24 hours at 37.5°C. before use in order to 
ensure sterility and to effect optinal drying for inoculation of dilutions of the test substances. 
Cultures as well as tissue emulsions were diluted in 0.1 per cent bovine albumin in distilled 
water. A 0.2 ml. calibrated serologic micropipette was used to deliver 0.02 ml. of the appro- 
priate dilution onto the surface of the medium. At least three replicates of each dilution were 
plated. The plates were sealed with adhesive tape  (to prevent evaporation) and incubated 
at 37.5  ° C. 
Colony counts were performed as routine at 2 and 3 weeks after incubation. When absence 
of growth was a feature, incubation was extended to a minimum of 4 weeks, and generally to 
7 weeks. Two observers made independent counts of the plates at the final reading. The cal- 
culation of the total number of colonies (expressed as culturable units of tubercle bacilli) per 
milliliter of tissue was performed by utilizing the dilution factors and the number of colonies 
(preferably in the range of 5 to 50) counted at the appropriate dilution. The logarithms of 
these numbers were plotted graphically as a function of time after initiation of infection. The 
s Kindly supplied as nydrazid by the E. R. Squibb and Sons, Division of the Olin Mathieson 
Chemical Corporation. 
s Kindly  supplied  as  aldinamide by  the  Lederle  Division  of  the  American  Cyanamid 
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resulting curves were taken to represent the fate of the tubercle bacillus during the natural 
course of infection as well as its fate under the influence of treatment with various regimens 
of antituberculous drugs. 
Considering the dilution that is necessary for preparing the tissue emulsion as well as the 
practical limitation of the volume of the organ enumerated, it is obvious that this method 
has a  lower limit with respect to its ability to detect culturable tubercle bacilli. The lower 
limits of the sensitivity of the method vary with the organ size and the number of replicates 
plated,  and  accordingly will  be used  to  qualify the  results of  certain experiments herein 
presented. 
All procedures performed with the use of infected material (the homogenization of tissues 
and the diluting and plating of the infected suspensions) were carried out in specially designed 
bacteriologic safety cabinets. These cabinets are closed during use except for armholes, and 
are fitted with exhaust fans which provide a steady slow inflow of air from the room. The air 
is exhausted through glass wool bacteriologic filters. All pipetting was done with a ring pipet- 
tot (8) attached to a vacuum so that no mouth pipetting was performed at any time. After 
use the interior of the hood was sprayed with 5 per cent phenol and irradiated  with ultra- 
violet light. 
RESULTS 
Untreated  A nimals.--In Text-fig. 1 may be seen the typical behavior of the 
populations of tubercle bacilli in  the lung and spleen of untreated mice ob- 
served over an 8 week period. 
Characteristically, on the day after infection the population in the lung was 
somewhat lower than in the spleen. Thereafter, the numbers of organisms in the 
lung progressively increased until they reached a  level of 1 X  10  s per ml. or 
slightly higher and the census then appeared to stabilize. Tuberculous lesions 
visible in the gross appeared in the lungs after 6 to 8 weeks of infection. From 
this point on, although the microbial census appeared to stabilize,  the pulmo- 
nary disease increased in extent and the animals died between the 4th and 6th 
month of infection. Autopsy of these animals revealed extensive pneumonic 
consolidation. 
In  the  spleen,  the  population  increased  initially,  but  quickly  reached  a 
peak, distinctly lower than the peak reached in the lung. Following this there 
was a  fall in census and then stabilization of the splenic population at a  re- 
markably constant level for the remainder of the period of observation. These 
observations appear to confirm in all respects those reported by Pierce et al. (4) 
and will be seen to be reproduced in the control animals of experiments to be 
presented below. 
Streptomycin and Isoniazid.--In Text-figs. 2 and 3 may be seen the effects 
of streptomycin and isoniazid administered singly and concurrently. As may 
be seen in Text-fig. 2 the microbial population in the lungs of the untreated 
control  animals  followed the  pattern  described  above.  Streptomycin failed 
to reduce the initial census of tubercle bacilli, but maintained it at this initial 
level for the duration of the experiment. In contrast, in animals given isoniazid, 
a fall in the population of tubercle bacilli in the lung began at once and con- R.  M'.  MCCUNE~  Jlt.~  AND  R.  TOM.PSETT  741 
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tinued throughout. At 8 weeks, as indicated by the broken line, the population 
was below the limits of detection in one of three animals. When streptomycin 
and isonlazid were administered concurrently the reduction in population ap- 
peared to be slightly greater than that effected by isoniazid alone. 
In the spleens (Text-fig. 3) of the control animals, the populations of tubercle 
bacilli again showed the initial rise and the subsequent fall and the stabiliza- 
tion previously described. Moreover, in the animals treated with streptomycin 
an initial rise in the microbial population occurred in the spleen as it had in 
the untreated animals. The peak census reached, however, was not so high as 
in  the  control  animals  which  had  received no  streptomycin.  The microbial 
census then fell and stabilized after approximately 3 weeks, remaining there- 
after at a  fairly constant level for the remainder of the experimental period. 
In contrast to the effect of streptomycin, in the animals which received iso- 
niazid a  fall in the population of tubercle bacilli in the spleen began at once. 
The rate of fall in the early weeks was rapid but thereafter a notable alteration 
in the curve ensued, with stabilization of the population at a low level, approxi- 
mately 1 X  104 organisms per ml. of spleen. This phenomenon was quite con- 
sistent as will be seen in subsequent experiments. 
Although the populations in the spleen were always found to be low in the 
animals treated with isoniazid alone, in no instance was there a  failure to re- 
cover tubercle bacilli. This is quite a different situation from that encountered 
in the lung, in which the populations of tubercle bacilli fell below the limits of 
detection in a number of instances after 8 weeks or more of isoniazid therapy. 
In Text-fig. 3 are shown the results obtained in the spleens of animals which 
received both  isoniazid and streptomycin. Again,  as in  the lung,  the values 
observed seemed consistently lower than in animals which received only iso- 
niazid. 
In Text-figs. 4 and 5 are presented data from similar experiment which was 
extended over a 4 month period and in which more animals were used for each 
observation period. As may be seen, the results were essentially the same as in 
the experiments presented in Text-figs. 2 and 3. At every observation point, 
the populations of tubercle bacilli in the tissues of the animals  treated with 
isonlazid and streptomycin together, were slightly but significantly lower than 
those from the animals treated with isoniazid alone. 
Drug Susceptibility  in vitro of Tubercle Bacili  Which Survived  despite Anti- 
microbial Therapy.--The strains of tubercle bacilli which had survived in the 
mouse tissues throughout therapy with isoniazid and streptomycin used singly 
and together were treated for susceptibility to these drugs in vitro. 
A  quantitative method was employed which consisted of inoculating measured aHquots 
of the tissue homogenates onto culture medium containing isoniazid concentrations of 0.1, 
1.0, and 10.0/zg. per ml. or streptomycin concentrations  of 1.0 and 10.0  #g. per ml. This pro- 
cedure was performed  as routine in the latter phases of the experiments, R.  ~r.  ~cCUZ~  ~t.~  AND R.  TOMZ~S~Tr  745 
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Tubercle bacilli resistant to streptomycin (i.e. capable of growth in drug con- 
centrations of 1.0 ~g. per ml.) represented less than 2 per cent of any individual 
population  of  tubercle  bacilli  in  the  animals which  received  streptomycin 
therapy for  the  12  week  period.  With  respect  to  isoniazid,  the  individual 
populations of tubercle  bacilli were likewise almost wholly composed of drug- 
susceptible  cells with the exception of the strains isolated from four animals. 
2 of these 4 strains were approximately evenly divided among tubercle bacilli 
which were susceptible to isoniazid concentrations  of 1.0 ~g. per ml. and bacilli 
which  were  resistant to  this concentration. The other two strains consisted 
entirely of tubercle  bacilli  resistant to the 10.0 ~g. per ml. concentration of 
isoniazid. 1 of these 2 completely resistant strains was isolated from an animal 
in which  an apparent resurgence  to a  high population had occurred  despite 
continued therapy with isoniazid alone. The other strain was found in an ani- 
mal in which a drug-induced  fall in census was apparently being maintained. 
In the observations  as a  whole,  therefore,  there was no correlation  between 
the persistence of tubercle bacilli in the tissues despite continued antimicrobial 
therapy and the resistance of these tubercle bacilli in vitro to the drug used in 
the antimicrobial therapy. 
Para-Amino  Salicylic  Acid with Streptomycin  and Isoniazid.--In  Text-figs. 
6 and 7 the data are presented on the populations of tubercle  bacilli  in the 
lung and spleen of animals which  received para-amino  salicyclic acid (PAS) 
administered either alone or with streptomycin or isoniazid. 
The results  observed  in the lungs of the control animals  (Text-fig. 6)  and 
in those  of the animals given  isoniazid  or streptomycin may be seen  to be 
closely  similar  to  those  previously  presented.  The  administration of  PAS 
alone prevented an increase in the total population of tubercle  bacilli during 
the first 3 weeks. Thereafter despite  continuation of the PAS  therapy there 
was an increase in the population of tubercle  bacilli above the original level. 
The administration of PAS and streptomycin together notably enhanced the 
total antimicrobial action and this  two-drug  regimen  effected a  distinct re- 
duction in the microbial  population in the lung.  The administration of PAS 
and isoniazid together, however,  did not significantly increase the total anti 
microbial  effect over that produced by the latter drug when used alone. 
In the spleen (Text-fig. 7), the microbial populations  in the untreated ani- 
mals and in those which received streptomycin or isoniazid singly were similar 
to  the results  in previous  experiments.  In the animals which  received  PAS 
alone there was a  slow, steady increase  in the number of tubercle bacilli  so 
that by the end of the experiment  the populations in the PAS-treated animals 
approximated those present in the control animals. The enhancing effect when 
PAS  and streptomycin were  given  together was  notable in that the initial 
multiplication which  occurred  with streptomycin alone failed to occur  when 
PAS  was administered along with the streptomycin. As in the lung, the ad- 748  ~ATE  OF  ~ZCOBACTER.IlY~  TUBERCULOSIS  IN  TISSUES.  I 
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ministration of PAS along with isoniazid had no greater effect on the popula- 
tions of tubercle  bacilli in the spleen, than was the case when isoniazid was 
given alone. 
It will be noted in Text-figs. 6 and 7 that the curves of the population data 
for the animals which received streptomycin are abbreviated. Due to an acci- 
dent which occurred in the animal quarters a number of the mice in this ex- 
perimental subgroup  were inadvertently killed  and thus insufficient numbers 
remained for sampling. An additional experiment  was done  therefore  (Text- 
figs. 8 and 9) in which animals received streptomycin and PAS together for an 
118 day period. As may be seen in Text-figs. 8 and 9 the populations of tubercle 
bacilli in both lung and spleen followed the same course under chemotherapy 
as was observed  in the present experiment  portrayed in Text-figs.  6  and  7 
After 3 weeks of treatment with both streptomycin and PAS,  the census of 
tubercle bacilli in the spleen had become stable and persisted unchanged there- 
after throughout the remainder of the 118 day period of therapy. 
Isoniazid-Streptomycin-PAS  Administered  together.--The  principal  object 
of the next experiment  (Text-figs. 10 and 11) was to determine the effects on 
the populations  of tubercle  bacilli  in the mice  when  three drugs,  isoniazid, 
streptomycin,  and  PAS  were  administered  together.  As  mentioned  above, 
an additional subgroup  of animals  in this experiment  received  streptomycin 
along with PAS and another subgroup  received isoniazid alone. 
As may be seen in Text-fig.  10,  administration of all  three drugs  together 
resulted in a reduction in the census of tubercle bacilli in the lung comparable 
with that observed  with isoniazid alone. On the last day of this experiment 
(i.e.  the  118th day of chemotherapy) a  technique  of considerably  increased 
sensitivity was used  for detection of the surviving  tubercle  bacilli. Whereas 
the technique  used previously had permitted the detection of 70 to 90 cultur- 
able units per lung, the new technique  permitted the detection of 1 to 3 cul- 
turable units per lung. By use of the more sensitive technique  it was possible 
to demonstrate the persistence of tubercle bacilli in the lungs of all of the ani- 
mals which had received the 3 drugs together. Only the less sensitive technique 
was used in the determinations made in the animals which received isoniazid 
alone  and bacilli  could be  detected in only three animals. 
In the spleen (Fig.  11)  the administration of isoniazid, streptomycin, and 
PAS  together,  was followed by a  reduction in the census of tubercle  bacilli 
to a  point slightly below that produced  by isoniazid  alone  but  comparable 
with the levels previously  observed  with isoniazid-PAS or isoniazid-strepto- 
mycin. Of particular interest was the fact that stabilization  of the population 
of tubercle  bacilli in the spleen occurred during the triple  drug therapy. The 
microorganisms persisted  throughout the entire period  of antimicrobial  ther- 
apy in a fashion identical with that observed with the previously studied single 
and multiple drug regimens. R.  M.  McCUNE~  JR.~  AND  R.  TOMPSETT  753 
I  I 
I 
.o 
I 
~'~  . 
~  0 
0  0  o 
go  o  ° 
\ 
I  ".'- "~  ~=  =.~  ,~  -~ 
I  I  .~c~  ~'~.~  .~  ~.~ 
~,,~  ~ 
I  ~,9  _~  ~ 
,  .~  ~  .2  o 
'  I  ~,  ~  I._1  ~ 
I  ',*  ~  ,~  ~  ~  ~o 
I  ~~=  ~  ~. 
~x  -- 
~/~  ~  .~ 
,:  ~  o  ~,~  ,.~..~ 
.,,.  ~  e~0,~  ~  ~  ~  -~ 
9NN"ILIW ~3d (ASL~H) ITIIO'~ 3"10~3gN1 c~dJNfl 3"IgVIA 754  FATE  O]~  MYCOBACTERIUM  TUBERCULOSIS  IN  TISSUES.  I 
J 
0  O0  I~1 
t  / 
] 
o  d ~ 
// 
-  /  i 
e.~  ,^ 
o  .~ 
~o 
~d 
. 
N  ~ 
e~ R.  M.  MCCUNE,  JR.,  AND  R.  TOMPSETT  755 
Pyrazinamide and Isoniazid.--In Text-fig. 12 may be seen the effects of pyra- 
zinamide and isoniazid on the populations of tubercle bacilli in the lung. The 
behavior of the microbial populations in  the  untreated  control animals  and 
in those which received isoniazid alone was the same as seen previously. Pyra- 
zinamide alone proved surprisingly effective during the first 2 months of ad- 
ministration at the end of which time no tubercle bacilli could be cultured from 
the lungs of any of the  three animals  tested. At  the end of the 3rd month, 
however,  there  had  been  a  marked  increase  in  the  populations  of  tubercle 
bacilli in two of the three animals.  (The less sensitive technique for detection 
of the tubercle bacilli was used in these experiments.  ) The apparent resurgence 
of the microbial populations in the lungs during  therapy with  pyrazinamide 
alone was of particular interest because the time relationships roughly coincide 
with those observed in the clinical relapse of tuberculosis in patients treated 
with this drug (5). 
The administration of pyrazinamide and isoniazid together was more effec- 
tive than with either drug alone. No tubercle bacilli could be cultured from the 
lungs of one of the  three animals examined at 3  weeks, and  throughout the 
remainder of the  experiment no  tubercle bacilli  could be  cultured from the 
lungs of any of the animals at any of the observation points. 
The fate of the bacilli in the spleen in this pyrazinamide-isoniazid experiment 
was of particular interest as may be seen in Text-fig. 13. When pyrazinamide 
and  isoniazid  were administered  together,  there  was  first  an  apparent  an- 
tagonism of the isoniazid, for the census of tubercle bacilli fell less rapidly than 
in the animals which received isoniazid alone. After the first 2 weeks of therapy, 
however, the situation was reversed and the microbial census in the animals 
which received pyrazinamide and isoniazid together fell steadily until it even- 
tually fell below the limits of detection. 5  weeks after the start of therapy, 
no tubercle bacilli could be cultured from the spleen of one of two animals, 
after 8 weeks there were no culturable bacilli in  the spleens of two of three 
animals and after 12 weeks there were none in any of the three animals ex- 
amined. 
The course of the microbial populations in the untreated control animals and 
in those which received isoniazid alone, was the same as in the previous experi- 
ments. Pyrazinamide when administered alone, prevented any increase in the 
census of tubercle bacilli in the spleens and after 2 weeks of therapy, the popu- 
lations showed a slight fall. 
This effect of a marked reduction in the populations of tubercle bacilli in the 
spleen after the administration  of pyrazinamide and isoniazid together, was 
in sharp contrast to the effects noted with the other drugs used either singly 
or in the various multiple drug regimens. With all the other chemotherapies 
studied  the populations of tubercle bacilli invariably persisted in  the  spleen 
with a  stable census after an initial fall of greater or lesser magnitude. 
In the experiment shown in Text-figs. 12 and 13, the number of animals sacri- 756  FATE  OF  M-YCOBACTERID~  TUBERCULOSIS  IN  TISSUES.  I 
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riced at each observation point was relatively small. Nevertheless, the phenome- 
non was so unique that it received further intensive study the results of which 
are presented in an accompanying report (9). Suffice it to say at this point that 
the  basic  observation  has  been  repeatedly  confirmed,  namely,  that  tubercle 
bacilli uniformly disappear from the spleens only in those animals which have 
received pyrazinamide along with another drug. 
ttistopathologic Studies.--Any  of the drugs or multiple drug regimens studied 
in the preceding experiments,  provided sufficient antimicrobial action  to pre= 
vent the development of macroscopic lesions when chemotherapy and infection 
were  started  on  the  same  day.  Nevertheless,  the  number  of  tubercle  bacilli 
present  within  the  infected  organs  showed  considerable  variation  depending 
upon  the  chemotherapy  employed.  The  particular  pattern  of  the  microbial 
population change produced by any one of the drugs or multiple drug regimens 
was characteristic for that drug regimen within any one of the  sets of circum- 
stances studied.  It seemed important,  therefore, to examine the tissues micro- 
scopically to determine  whether  the  tissue  changes of the  tuberculous  lesions 
could  be  related  to  the  pattern  of the  microbial  population  changes  charac- 
teristic  for the  individual  chemotherapies.  Accordingly, sections  of lung  and 
spleen were made from the animals of various groups at the termination of the 
experiments and the results of the examination of this material may be briefly 
summarized. 
The control untreated animals showed the characteristic  tissue changes associated with 
experimental tuberculous infections of mice. The lungs (Fig. 1) showed dense confluent areas 
of cellular infiltration, with marked proliferative inflammation and small areas of necrosis. 
The spleens were markedly enlarged, and on microscopic section showed intensive hyper- 
plasia, with many focal areas of proliferation. Acid-fast bacilli were numerous in both organs. 
In animals treated with PAS (Fig. 2) the lungs showed considerably less cellular infiltra- 
tion,  especially involving the alveoli. Nevertheless,  large areas  of proliferative  infiltration 
persisted, particularly  involving the alveolar septa. The spleens were somewhat less hyper- 
plastic than in the untreated  animals, but the difference was not marked. Tubercle bacilli 
were numerous in both organs. 
Figs. 3 to 9 are photomicrographs of the lungs of animals given isoniazid, streptomycin, 
and pyrazinamide singly, as well as the following multiple drug regimens: streptomycin  and 
PAS, isoniazid and PAS, isoniazid, streptomycin and PAS, and isoniasid and pyrazinamide. 
Minor differences in the amount of residual inflammation can be detected from one animal 
to another, but the striking feature is how little infiltration could be detected in any of the 
lungs from the animals treated  on these various regimens. Some thickening of the alveolar 
septa was present in all of the groups except for those animals treated with pyrasinamide and 
isonizid. In this particular  group, after 12 weeks of treatment,  the lungs appeared  entirely 
normal. In the spleens, from all groups of animals, some slight hyperplasia was present,  the 
least amount again being noted in the animals which received pyrasinamide  and  isoniazid 
together. 
A prolonged search was made for acid-fast bacilli in the sections of both lung and spleen 
from those groups of animals represented in Figs. 3 to 9. In general, this search  was most 
unrewarding. A rare tubercle bacillus was found in an organ with  a concentration of bacilli R.  M.  McCUNE,  JR.,  AND  R.  TOMPSETT  759 
as low as 1 X 10  4 per ml. The difficulty  in finding acid-fast bacilli increased markedly, how- 
ever, as the concentration fell below 1 X 10  6 per ml., and the bacilli could not be found with 
any degree of regularity when the total population was below 1 X 10  5  per ml. 
DISCUSSION 
From the above observations it may be seen that the influence of antimicro- 
bial  drugs  on populations  of  tubercle bacilli  (H37Rv)  persisting  in  mice  is 
considerably different depending on whether the tubercle bacilli are  situated 
in the lung or in the spleen.  This difference between  the  2  organs  in  terms 
of drug-parasite relationships is analogous to the difference which  exists be- 
tween them with  respect to host-parasite  relationships.  The latter  phenom- 
enon was reported previously by Pierce, Dubos,  and  Schaefer  (4)  and  has 
been  observed repeatedly in the untreated control groups  of animals  in  the 
present investigation. 
In the spleen, the  infection appeared  to  be somewhat less active than  in 
the lung as judged by the height of the maximal splenic populations attained 
and the slow steady  fall in census  which  occurred thereafter. By  the  same 
token, in the spleen the  influence  of most  antimicrobial  drugs  was  consid- 
erably less marked than when the same drugs were acting on tubercle bacilli 
situated in the lung. 
Thus the infection appeared to be subjected to stronger natural limiting in- 
fluences in the spleen but this was  not accompanied by any increase in the 
effectiveness of the antimicrobial drugs.  It is clear, therefore, that the drug- 
parasite and the host-parasite reactions are distinctive for each of the two or- 
gans.  It  is  not  clear,  however, how  the  particular  environment which  each 
organ provides for the tubercle bacilli, exercises its influence on what may be 
attained therein by anthnicrobial therapy. 
Comparative examinations of the influence of the various antimicrobial drugs 
on the number or character of the  tuberculous lesions appeared  to be a  far 
less sensitive index of antimicrobial drug effectiveness than determinations of 
the census of culturable tubercle bacilli within the organs.  For example, the 
lungs from many of the various drug  therapy groups were indistinguishable 
one from another in  terms of the  extent of lesions or  their appearance.  In 
terms of the size of the populations of tubercle bacilli within these same lungs, 
however,  there  were marked  differences which  were  characteristic  and  uni- 
formly predictable for the  particular  drug  or drug  regimen employed. This 
similarity in histopathologic appearance  despite wide variation in population 
size may simply reflect differences in the time required to effect the separate 
processes of reducing the microbial population and healing the lesions. Finally, 
in this connection it is of interest to note that the population of tubercle bacilli 
does not have to be increasing in order for the lesions to continue to progress. 
Once a population of tubercle bacilli attained a sufficiently high level, as in the 760  FATE  OF  MYCOBACTERIUM  TUBERCULOSIS  IN  TISSUES.  I 
untreated animals,  the resulting pulmonary lesions showed a steady progression 
thereafter even though the size of the population remained stable. 
In the present studies,  isoniazid was clearly the most effective single drug in 
reducing the number of tubercle bacilli in both lung and spleen. Pyrazinamide 
was surprisingly effective and for short periods its potency approached that of 
isoniazid.  Subsequently, however, resurgence  of growth occurred in some of the 
pyrazinamide-treated  animals.  The effectiveness  of streptomycin in reducing 
the total microbial  population was appreciably less than  that  of isoniazid  or 
pyrazinamide.  Indeed,  during  the first  10 days of streptomycin therapy  the 
population of tubercle bacilli  in the spleen regularly showed an increase.  As 
might have been anticipated,  para-amino  salicylic  acid (PAS) showed a  rela- 
tively low order of effectiveness.  It is of interest,  moreover, that  the period 
during which PAS appeared to maintain its full antimicrobial effectiveness was 
limited  to  the first 3  or 4  weeks of therapy. 
The  technique of microbial enumeration  has also seemed to offer a  useful 
method for the evaluation of the effects of simultaneous administration  of 2 
or more drugs.  For example,  the population studies in both lung and spleen 
provided  evidence  that  the  effect  of  streptomycin  was  enhanced  by PAS. 
In contrast, PAS did not enhance the action of isoniazid.  Moreover, in all the 
regimens  tested including  the administration  of all  three drugs together,  the 
characteristic pattern of stabilization of the population in the spleen  was ob- 
served. 
Current  concepts of the biology of tuberculous infection stress the impor- 
tance of the ability of small numbers of tubercle bacilli to remain viable in rela- 
tively quiescent areas of disease for long periods of time. This ability to survive 
is generally considered  to be a major factor in the marked tendency to recru- 
descence exhibited by tuberculous lesions.  Clinical  experience  with the gener- 
ally accepted chemotherapeutic regimens provide ample evidence that none of 
these therapies is eradicative, and that recrudescence  of apparently quiescent 
lesions remains an important problem. In the studies herein reported the phe- 
nomenon of persistence of culturable tubercle bacilli  in the mouse spleen was 
regularly observed during therapy with isoniazid, streptomycin, and PAS given 
singly,  in pairs and all 3 simultaneously. Moreover, when subsequently tested 
in  ,qtro,  the  persisting  strains  of tubercle bacilli,  with few exceptions,  were 
susceptible to isoniazid or to streptomycin. 
In striking contrast to these effects were those observed with the combination 
of pyrazinamide and isoniazid.  With this therapy, reduction in the population 
of tubercle bacilli below detectable levels occurred earlier in the lung than with 
isoniazid  alone and moreover, it occurred with uniformity. A more unique ef- 
fect, however, was the uniform disappearance of the tubercle bacilli  from the 
spleen. It is obvious that it is extremely difficult to establish that the tubercle 
bacilli  had actually been eliminated from the tissues.  Nevertheless, the tech- R. M. McCUNE, JR., AND R. TOMPSETT  761 
niques employed in the present study are capable of detecting tubercle  bacilli 
when present in very small numbers. The mechanics of this phenomenon of the 
complete  disappearance  of tubercle  bacilli from the lung and spleen of mice 
which  received  pyrazinamide and isoniazid  have been subjected to detailed 
study and the results are presented in the succeeding report of this series (9). 
In other Studies in this laboratory (10) it has been established  that tubercle 
bacilli are not uniformly eliminated from the tissues of man by the concurrent 
administration of pyrazinamide and isoniazid although the treatment is highly 
effective. 
SUMMARY 
Observations are presented on the behavior of populations of tubercle bacilli 
in the tissues  of mice during the administration of antimicrobial drugs.  The 
behavior of the populations during therapy with any particular drug was dif- 
ferent depending upon whether the tubercle bacilli were subsisting in the lung 
or in the spleen. Moreover,  the pattern of microbial behavior was distinctive 
and predictable for each drug studied. Changes in the size of the populations 
of tubercle  bacilli in the tissues appeared  to be a more sensitive reflection of 
drug influence than microscopic study of the number and character of the tuber- 
culous lesions. Nevertheless,  in untreated animals, pulmonary lesions evolved 
and progressed steadily to a fatal outcome despite the fact that the populations 
of tubercle bacilli had stabilized at a relatively high census early in the course 
of therapy. 
The uniform persistence of tubercle bacilli in the spleen throughout prolonged 
drug administration was demonstrated with every drug or multiple drug regi- 
mens except for pyrazinamide when accompanied by isoniazid. Cultures of the 
bacilli which survived in the tissues despite antimicrobial therapy were highly 
susceptible  to the drugs employed when tested in ~ilro. Thus the survival of 
the tubercle bacilli in the tissues represented  microbial persistence rather than 
drug resistance. 
When pyrazinamide and isoniazid  were administered together, it was  not 
possible to detect the microorganisms in the spleen or lungs of treated animals. 
A detailed investigation of this apparent abolition of microbial persistence forms 
the subject of an accompanying report. 
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EXPLANATION  OF PLATES 
FIOS. 1 to 9. The series of plates are photomicrographs of lungs of mice from various 
experiments described  in the text. In each instance, the mice were infected by intra- 
venous inoculation  of approximately 2  X  106 culturable  units  of  tubercle  bacilli 
(H37Rv). Treatment was started on the day of infection and at the interval stated in 
the individual legend mice were sacrificed, the tissues were obtained for section,  and 
enumerations of the populations of tubercle bacilli were performed on the homogenized 
tissues of groups of animats as described  in the text. In each legend is indicated the 
drugs administered and the average population of tubercle bacilli in the lung at time of 
sacrifice. The magnification in each plate is approximately 100 X. Hematoxylin and 
eosin stain. 
PLATE 56 
FIG. 1. Untreated control, 12 weeks after infection. Microbial population: 6.5 ×  10  ~ 
culturable units of tubercle bacilli per ml. of homogenized  tissue. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 104  PLATE 56 
(McCune and Tompsett: Fate of Mycobacterium tuberculosis in tissues. I) PLATE 57 
FIG. 2. Treatment: PAS, 8 weeks.  Microbial population: 2.9  X  106 per ml. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL, 104  PLATE 57 
(McCune and Tomspett: Fate of Mycobacterium tuberculosis in tissues. I) PLATE 58 
FIG. 3. Treatment: Streptomycin 12 weeks.  Microbial population: 2  ×  10 ~ per ml. THE  JOURNAL  OF  EXPERIMENTAI,  MEDICINE  VOL.  104  PLATE 58 
(McCune and Tompsett: Fate of Mycobacterium tuberculosis  in tissues. I) PLATS 59 
FIG. 4. Treatment:Streptomycin and PAS 16 weeks. Microbial population: 1.3 X 103 
per ml. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  104  PLATE  59 
(McCune and Tompsett : Fate of Mycobacterium tuberculosis in tissues. I) PLATE 60 
FIG. 5. Treatment: Isoniazid 12 weeks.  Microbial population: 4.3  X  1@. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  104  PLATE  60 
(McCune and Tompsett : Fate of Mycobacterium tuberculosis in tissues. I) PLATE  61 
FIG. 6. Treatment: Isoniazid and PAS 8 weeks. Microbial population:  no  recover- 
able organisms (i.e.,  less than  1.5  X  102 per ml.) TItE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  10~  PLATE  61 
(McCune and Tompsett : Fate of Mycobacterium tuberctdosis in tissues. I) PLATE  62 
FIG. 7. Treatment: Isoniazid, Streptomycin and PAS 16 weeks. Microbial population 
1.5  X  10 ° per ml. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  104  PLATE 62 
(McCune and Tompsett : Fate of Mycobacterium tuberculosis in tissues. I) PLATE 63 
FIG. 8. Treatment: Pyrazinamide 8 weeks.  Microbial population: 2.3  ×  104 per ml. TIIE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  104  PLATE  63 
(McCt~ne and Tompsett : Fate of Mycobacterium tuberc~dosis in tissues. I) PLATE 64 
:FIG. 9.  Treatment: Isoniazid and  pyrazinamide  12  weeks.  Microbial population: 
no recoverable organisms (i.e.  less than  1 X  102 per ml.) THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  104  PLATE 64 
(McCune and Tompsett: Fate of Mycobacterium tuberculosis in tissues. I) 